Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Cardiol Cases ; 28(2): 86-90, 2023 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-37521578

RESUMEN

We present the case series of two women aged 35 and 60 years who presented to our emergency department with severe vomiting, nausea, and malaise. Their symptoms started approximately 2 h after the ingestion of home-made mixed vegetables with freshly picked vegetables and leaves from the patients' garden, of which one was supposed to be borage. An electrocardiogram revealed diffuse ST-segment depression with down-up sloping in both patients. We supposed an accidental confusion of wild borage (Borago officinalis) with foxglove (Digitalis purpurea). Both patients were subsequently admitted to the intermediate-care-unit for close monitoring and continuous activated charcoal administration. Digitoxin serum concentrations were elevated in both patients (40.9 and >50 ng/ml, respectively - reference therapeutic range 8-18 ng/ml). The younger woman, despite the relatively lower serum digitoxin concentrations, presented a single episode of advanced atrioventricular block and long-lasting sinus bradycardia. Both showed a complete recovery. Although not uncommon, our case series reiterates the fact that such plant misclassifications are potentially life-threating and warrant the treating physicians' full attention. Learning objective: Plant poisoning is a frequent reason for consultation of poison information centers and may result in life-threatening cardiac arrhythmias. Confusion of foxglove leaves (Digitalis purpurea) with borage leaves (Borago officinalis L.), which is a popular food ingredient for mixed salads, is not uncommon. Without a dedicated medical history, such cases are difficult to diagnose and warrant the treating physicians' full attention and the involvement of a local poison information center.

2.
Can J Diabetes ; 44(4): 301-303, 2020 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-31866240

RESUMEN

Dietary modifications play a central role in the treatment of diabetes. Educating and empowering individuals to make better dietary choices is a challenging task. In this context, 1 potential dietetic approach to achieve better glycemic control in type 2 diabetes is often overlooked: the use of short-term dietary oatmeal interventions. This concept was described more than 100 years ago by the German diabetologist Carl von Noorden. It is still applied in several German hospitals, but in a modified form. Although von Noorden initially prescribed a diet including oatmeal, butter and vegetables, some physicians nowadays tend to omit butter from the diet. The result is a hypocaloric, plant-based dietary intervention that is low in fat and excludes animal protein for a short period. This short-term dietary intervention has been associated with a significant reduction in mean blood glucose concentrations and an improved insulin sensitivity in patients with type 2 diabetes. Almost forgotten, short-term dietary oatmeal interventions are an economical, yet highly effective tool to achieve better glycemic control in patients with type 2 diabetes.


Asunto(s)
Avena/química , Diabetes Mellitus Tipo 2/dietoterapia , Dieta , Resistencia a la Insulina , Adulto , Humanos , Pronóstico
3.
Antimicrob Agents Chemother ; 60(1): 252-7, 2016 01.
Artículo en Inglés | MEDLINE | ID: mdl-26482315

RESUMEN

We determined the incidence, risk factors, and outcomes of bloodstream infections (BSI) subsequent to Clostridium difficile infection (CDI). We performed a retrospective study of all patients with definite diagnosis of CDI admitted from January 2014 to December 2014 in two large hospitals in Rome. Two groups of patients were analyzed: those with CDI and subsequent BSI (CDI/BSI(+)) and those with CDI and no evidence of primary BSI (CDI/BSI(-)). Data about clinical features, microbiology, treatments, and mortality were obtained. Overall, 393 cases of CDI were included in the final analysis: 72 developed a primary nosocomial BSI, while 321 had CDI without microbiological and clinical evidence of BSI. Etiologic agents of BSI were Candida species (47.3%), Enterobacteriaceae (19.4%), enterococci (13.9%), and mixed infections (19.4%). In multivariate analysis, ribotype 027 status (odds ratio [OR], 6.5), CDI recurrence (OR, 5.5), severe CDI infection (OR, 8.3), and oral vancomycin at >500 mg/day (OR, 3.1) were recognized as factors independently associated with the development of nosocomial BSI. Thirty-day mortality from CDI diagnosis was higher for patients of the CDI/BSI(+) group than for the controls (38.9 versus 13.1%; P < 0.001). Among patients of the CDI/BSI(+) group, mortality attributable to primary BSI was as high as 57%. Our findings suggest that severe CDI is complicated by the development of nosocomial BSI. Candida species and enteric bacteria appear to be the leading causative pathogens and are associated with poor outcomes.


Asunto(s)
Antiinfecciosos/uso terapéutico , Candidiasis/microbiología , Infecciones por Clostridium/microbiología , Infección Hospitalaria/microbiología , Infecciones por Enterobacteriaceae/microbiología , Infecciones por Bacterias Grampositivas/microbiología , Anciano , Bacteriemia/tratamiento farmacológico , Bacteriemia/microbiología , Bacteriemia/mortalidad , Bacteriemia/patología , Candida/efectos de los fármacos , Candida/crecimiento & desarrollo , Candida/patogenicidad , Candidiasis/tratamiento farmacológico , Candidiasis/mortalidad , Candidiasis/patología , Estudios de Casos y Controles , Clostridioides difficile/efectos de los fármacos , Clostridioides difficile/crecimiento & desarrollo , Clostridioides difficile/patogenicidad , Infecciones por Clostridium/tratamiento farmacológico , Infecciones por Clostridium/mortalidad , Infecciones por Clostridium/patología , Coinfección , Infección Hospitalaria/tratamiento farmacológico , Infección Hospitalaria/mortalidad , Infección Hospitalaria/patología , Enterobacteriaceae/efectos de los fármacos , Enterobacteriaceae/crecimiento & desarrollo , Enterobacteriaceae/patogenicidad , Infecciones por Enterobacteriaceae/tratamiento farmacológico , Infecciones por Enterobacteriaceae/mortalidad , Infecciones por Enterobacteriaceae/patología , Enterococcus/efectos de los fármacos , Enterococcus/crecimiento & desarrollo , Enterococcus/patogenicidad , Femenino , Infecciones por Bacterias Grampositivas/tratamiento farmacológico , Infecciones por Bacterias Grampositivas/mortalidad , Infecciones por Bacterias Grampositivas/patología , Humanos , Masculino , Metronidazol/uso terapéutico , Análisis Multivariante , Oportunidad Relativa , Factores de Riesgo , Análisis de Supervivencia , Resultado del Tratamiento , Vancomicina/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA